Key facts
- This page summarizes Barry Canton's Form 4 filing for Ginkgo Bioworks Holdings, Inc. (DNA).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 29 Apr 2024, 16:53.
Barry Canton - 25 Apr 2024 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- DNA
- Reported as of
- 25 Apr 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 29 Apr 2024, 16:53:58 UTC
- Prior SEC filing
- 22 Dec 2023
- Next SEC filing
- 10 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Karen Tepichin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Barry Canton filed Form 4 for Ginkgo Bioworks Holdings, Inc. (DNA) on 29 Apr 2024.
Change
- Previous filing in this sequence was filed on 22 Dec 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DNA
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +5,000,000
- Change %
- Price
- $0.000000
- Shares after
- 5,000,000
- Date
- 25 Apr 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 5,000,000
- Exercise price
- $2.50
- Footnotes
- F1
DNA
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +5,000,000
- Change %
- Price
- $0.000000
- Shares after
- 5,000,000
- Date
- 25 Apr 2024
- Ownership
- By Spouse
- Underlying class
- Class A Common Stock
- Underlying amount
- 5,000,000
- Exercise price
- $2.50
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The options are subject both to time-based and performance-based vesting criteria (the "Founder Options"). The performance-based vesting is tied to the achievement of four specified stock price hurdles within a five-year period, with 10% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $5.00, 10% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $7.50, 20% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $10.00 and the remaining 60% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $12.50. If any of the performance-based criteria are achieved during the five-year performance period, the awards will vest on the five-year anniversary of the grant date, subject to the Reporting Person's or spouse's continued employment with Ginkgo on such anniversary.